Vinati Kastia
Senior Partner
DelhiPractice Area
Sectors
While Corporate / Mergers & Acquisitions and Private Equity are my core practice areas, I also enjoy working on litigation matters, particularly on the strategy side. I have been able to work alongside our Dispute Resolution team on some path breaking litigation, which has been a very enriching experience. I have also worked on several pro-bono assignments and the cause I am most passionate about is gender neutrality and diversity.
Excellent domain knowledge.
Client Recommendation – RSG India Report (2019)With over 25 years of experience, Vinati Kastia advises on a wide range of corporate and commercial transactions with a deep knowledge of public and private M&A and private equity transactions. She has worked on several cross–border M&A transactions, both inbound and outbound and also has extensive experience in corporate restructurings, including court/tribunal approved mergers, de–mergers and capital restructurings. Vinati’s industry experience is diverse and includes manufacturing, retail, telecom, infrastructure, solar energy, media, broadcasting, alcoholic and non–alcoholic beverages, hospitality, healthcare, pharmaceuticals, e–commerce, insurance and financial services, direct selling and real estate. She also engages on corporate, regulatory and compliance advisory for various domestic and international clients.
WORK HIGHLIGHTS
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
-
On various Corporate Advisory, Compliance and Regulatory matters
-
With respect to investigations, corporate advisory, compliance and M&A matters
-
On the (i) Divestment of ‘Horlicks’ and other consumer healthcare nutrition brands to Unilever and merger of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited (ii) Disposal of its entire shareholding in HUL, for an aggregate consideration of INR 254.8 billion, the largest ever block deal in India
-
On (i) agroup restructuring through a composite scheme of arrangement involving the amalgamation and demerger of the life science business into a separate entity (ii) The cross-border arrangement to acquire exclusive rights from PLK Pte Ltd to develop and operate Popeyes restaurants in India, Bangladesh, Nepal and Bhutan
-
On forensic investigations, compliance, general advisory and regulatory matters
-
On its investments in Delhivery, Brainbees, PayTM E-commerce and Flipkart
RECENT RECOGNITION
2024
2023
2022
2021
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
Asian Legal Business
Named among ‘ALB India’s Top Female Lawyers’
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Private Equity & Investment Funds
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate / M&A and Private Equity & Investment Funds
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for TMT
RECENT RECOGNITION
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
Asian Legal Business
Named among ‘ALB India’s Top Female Lawyers’
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Private Equity & Investment Funds
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate / M&A and Private Equity & Investment Funds
Asialaw Profiles
‘Distinguished Practitioner’ for Private Equity
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for TMT